Site-specific adaptive nanovesicles for oral insulin delivery. [PDF]
Xia B +19 more
europepmc +1 more source
Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report. [PDF]
Maqsood H, Fleming J.
europepmc +1 more source
OA25 Efficacy and safety of nipocalimab, an anti-FcRn monoclonal antibody, in primary Sjogren’s disease: results from a Phase 2, multicenter, randomized, placebo-controlled, double-blind study (DAHLIAS) [PDF]
Jacques-Éric Gottenberg +8 more
openalex +1 more source
Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction. [PDF]
Tarasco MC +14 more
europepmc +1 more source
Model-Informed Optimal Dosing of Anti-CD47 Antibody Using Target-Mediated Drug Disposition Model. [PDF]
Jeong S +6 more
europepmc +1 more source
Lactobacillus johnsonii-derived extracellular vesicles restore mucosal immunity via taurine-linked Th17/Treg and IgA/IgG regulation in colitis. [PDF]
Zhao H +13 more
europepmc +1 more source
Potential drug interaction between calcitonin gene-related peptide antagonists and neonatal Fc receptor inhibitors. [PDF]
Harlan A, Weber K.
europepmc +1 more source
A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In Vivo. [PDF]
Peng S +11 more
europepmc +1 more source
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties. [PDF]
Aaen KH +15 more
europepmc +1 more source

